Paper
Glimepiride exhibits prophylactic effect on atherosclerosis in cholesterol-fed rabbits.
Published Oct 1, 2005 · Shuji Shakuto, K. Oshima, E. Tsuchiya
Atherosclerosis
Q1 SJR score
15
Citations
1
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Glimepiride prevents atherosclerosis development in fat-fed rabbits, potentially due to inhibition of endothelial cell-mediated LDL oxidation.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
···
···
···
···
Citations
RABBIT: AN ANIMAL AT THE NEXUS OF FOOD PRODUCTION AND BIOSCIENCE RESEARCH FOR SUSTAINABLE DEVELOPMENT IN DEVELOPING COUNTRIES
Rabbit production is a cost-effective, sustainable solution for increasing protein supply in developing countries and serves as a model animal for studying human diseases and metabolic dysfunctions.
2020·3citations·A. Sikiru et al.·Tropical and Subtropical Agroecosystems
Tropical and Subtropical Agroecosystems
Hypocholesterolemic Effect of Potential Probiotic Lactobacillus fermentum Strains Isolated from Traditional Fermented Foods in Wistar Rats
Lactobacillus fermentum strains PH5 and PD2 effectively reduce serum cholesterol, LDL-cholesterol, and triglycerides levels in rats, potentially benefiting high cholesterol management in Indian populations.
2019·21citations·P. Thakkar et al.·Probiotics and Antimicrobial Proteins
Probiotics and Antimicrobial Proteins
Differences between Mitiglinide/Voglibose Fixed-dose Combination and Glimepiride in Modifying Low-density Lipoprotein Heterogeneity in Japanese Type-2 Diabetic Patients: A Pilot Study
Mitiglinide/voglibose fixed-dose combination and glimepiride show different effects on LDL-metabolism in type-2 diabetic patients, potentially affecting blood glucose fluctuations.
2015·2citations·S. Tani et al.·Drug Research
Drug Research
Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin
Pioglitazone improves the cardio-ankle vascular index (CAVI) in patients with type 2 diabetes mellitus treated with metformin, reducing arterial stiffness without affecting blood pressure.
2014·30citations·M. Ohira et al.·Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Effects of glimepiride and glibenclamide on carotid atherosclerosis in type 2 diabetic patients.
Glimepiride significantly reduces carotid atherosclerosis progression in type 2 diabetic patients compared to glibenclamide.
2011·7citations·N. Katakami et al.·Diabetes research and clinical practice
Diabetes research and clinical practice
Worsening of Diet-Induced Atherosclerosis in a New Model of Transgenic Rabbit Expressing the Human Plasma Phospholipid Transfer Protein
Human PLTP expression in transgenic rabbits worsens atherosclerosis by increasing atherogenic apoB-containing lipoproteins without altering their antioxidative protection or cholesterol content of plasma HDL.
2011·42citations·D. Masson et al.·Arteriosclerosis, Thrombosis, and Vascular Biology
Arteriosclerosis, Thrombosis, and Vascular Biology
Lipid Lowering and Antioxidant Effects of Newly Synthesized 4-((Butylsulfinyl)methyl)-1,2-benzenediol (SMBD) in Diet-induced Hypercholesterolemic Rabbits
SMBD significantly reduces cholesterol levels and inhibits aortic intimal thickness in hypercholesterolemic rabbits, offering significant prevention against the condition.
2010·4citations·H. J. Kim et al.·Bulletin of The Korean Chemical Society
Bulletin of The Korean Chemical Society
The differentiating effect of glimepiride and glibenclamide on paraoxonase 1 and platelet-activating factor acetylohydrolase activity.
Glimepiride and glibenclamide have no beneficial effects on circulating PON1 and PAF-AH activities, but both drugs increase PON1 activity in the liver.
2010·21citations·G. Wójcicka et al.·Life sciences
Life sciences